A new drug combination may simplify hepatitis C treatment for both patients and physicians, suggests a new study. The once-daily sofosbuvir-velpatasvir pill aims to simplify treatment for the majority of hepatitis C physicians and their patients.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1OWafRw
No comments:
Post a Comment